Leaderboards/Chemotherapy-induced cardiotoxicity and mitigation

Chemotherapy-induced cardiotoxicity and mitigation

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Weibin He
Economic Research Institute
2
S. Pravin
King Edward Memorial Hospital and Seth G.S. Medical College
3
Matthias Bosman
University of Antwerp
4
Hsuan-Chia Chang
Chang Gung University
5
Patricia Lorena Dulf
Iuliu Hațieganu University of Medicine and Pharmacy
6
Carl W. Belger
University of the Witwatersrand
7
Albulena Mecinaj
University of Oslo
8
Estíbaliz Díaz-Balboa
Universidade de Santiago de Compostela
9
Sandy R. Botros
Minia University
10
Wei Zhang
Jiangnan University

Papers

1
Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy–Related Cardiac Dysfunction
JACC CardioOncology|2024
45 cit.
2
Publication in Progress in Cardiovascular Diseases (2024) [35 citations, W4392005466]
Progress in Cardiovascular Diseases|2024
35 cit.
3
Mitigating Doxorubicin-Induced Cardiotoxicity through Quercetin Intervention: An Experimental Study in Rats
Antioxidants|2024
19 cit.
4
Publication in Atherosclerosis (2025) [2 citations, W4408731913]
Atherosclerosis|2025
2 cit.
5
Publication in Physiotherapy (2025) [2 citations, W4408891306]
Physiotherapy|2025
2 cit.
6
Publication in JACC CardioOncology (2024) [W4399998490]
JACC CardioOncology|2024
0 cit.
7
Publication in Atherosclerosis (2024) [W4401599834]
Atherosclerosis|2024
0 cit.
8
Publication in Fisioterapia (2024) [W4402467499]
Fisioterapia|2024
0 cit.
9
Publication in International Journal of Pharmaceutical and Phytopharmacological Research (2024) [W4404904860]
International Journal of Pharmaceutical and Phytopharmacological Research|2024
0 cit.
10
Publication in Atherosclerosis (2025) [W4413268622]
Atherosclerosis|2025
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Daniel Muñoz
Association of Chartered Certified Accountants
2
Stefan Agewall
University of Oslo
3
Alexander R Lyon
Royal Brompton Hospital
4
Nigora Srojidinova
Tashkent Pediatric Medical Institute
5
Riccardo Asteggiano
University of Insubria
6
Jennifer Cautela
Hôpital Nord
7
Jun Wan
Wuhan University
8
David J. Cutter
Cancer Research UK Oxford Centre
9
Carmine Gentile
University of Technology Sydney
10
Md. Shenuarin Bhuiyan
Louisiana State University Health Sciences Center Shreveport

Papers

1
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
European Heart Journal - Cardiovascular Imaging|2022
491 cit.
2
MCC950, a Selective NLRP3 Inhibitor, Attenuates Adverse Cardiac Remodeling Following Heart Failure Through Improving the Cardiometabolic Dysfunction in Obese Mice
Frontiers in Cardiovascular Medicine|2022
47 cit.
3
Resolvin D1 Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Inflammation, Oxidative and Endoplasmic Reticulum Stress
Frontiers in Pharmacology|2022
29 cit.
4
Anti-Oxidative, Anti-Apoptotic, and M2 Polarized DSPC Liposome Nanoparticles for Selective Treatment of Atherosclerosis
International Journal of Nanomedicine|2023
29 cit.
5
3D bioprinted alginate-gelatin hydrogel patches containing cardiac spheroids recover heart function in a mouse model of myocardial infarction
Bioprinting|2023
25 cit.
6
Mitochondrial dysfunction and autophagy activation are associated with cardiomyopathy developed by extended methamphetamine self-administration in rats
Redox Biology|2022
24 cit.
7
Microglia‐Mediated Neuroimmune Response Regulates Cardiac Remodeling After Myocardial Infarction
Journal of the American Heart Association|2023
20 cit.
8
Diastolic dysfunction in Alzheimer’s disease model mice is associated with Aβ-amyloid aggregate formation and mitochondrial dysfunction
Scientific Reports|2024
19 cit.
9
The association between outdoor air pollution and body mass index, central obesity, and visceral adiposity index among middle-aged and elderly adults: a nationwide study in China
Frontiers in Endocrinology|2023
17 cit.
10
Biofabrication of advanced in vitro 3D models to study ischaemic and doxorubicin-induced myocardial damage
Biofabrication|2022
16 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Patrizio Lancellotti
Centre Hospitalier Universitaire de Liège
2
Per Hall
Karolinska Institutet
3
Flora E. van Leeuwen
The Netherlands Cancer Institute
4
Thomas H. Marwick
The University of Queensland
5
Marielle Scherrer‐Crosbie
University of Pennsylvania
6
Rhian M. Touyz
McGill University Health Centre
7
Daniel J. Lenihan
Saint Francis Medical Center
8
Thomas Suter
University of California San Diego
9
Steven E. Lipshultz
Jacobs Institute
10
Pawan K. Singal
University of Manitoba

Papers

1
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
New England Journal of Medicine|2013
4k cit.
2
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
European Heart Journal|2022
2.8k cit.
3
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
European Heart Journal|2016
2.5k cit.
4
Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Journal of the American Society of Echocardiography|2014
1.8k cit.
5
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)
European Journal of Echocardiography|2010
1.5k cit.
6
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
New England Journal of Medicine|1991
1.4k cit.
7
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Journal of Clinical Oncology|2017
1.3k cit.
8
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
European Heart Journal|2022
1.1k cit.
9
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
European Heart Journal - Cardiovascular Imaging|2014
1.1k cit.
10
Incidence, Causes, and Outcomes of Dilated Cardiomyopathy in Children
JAMA|2006
1k cit.

Reagents for Chemotherapy-induced cardiotoxicity and mitigation

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

Phospho-Bad (Ser155) Antibody

Cited in 6 papers
#9297$148,362
View Evidence →
Cell Signaling TechnologyEvidence 65

EGF Receptor (D38B1) Rabbit Monoclonal Antibody (PE Conjugate)

Cited in 6 papers
#8839$465
View Evidence →
MedChemExpressEvidence 60

Doxorubicin

Cited in 5 papers
#HY-15142
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

Phospho-NDRG1 (Thr346) Matched Antibody Pair

Cited in 8 papers
#33585$1,726
View Evidence →
Cell Signaling Technology

Caspase-5 (D3G4W) Rabbit Monoclonal Antibody

Cited in 7 papers
#46680$161,351
View Evidence →
Cell Signaling Technology

Phospho-p53 (Ser20) Antibody

Cited in 6 papers
#9287$148,362
View Evidence →